Cardiogenic Shock

This page includes content on technologies to treat cardiogenic shock, including percutaneous ventricular assist devices (pVAD), intra-aortic balloon pumps (IABP) and extracorporeal membrane oxygenation (ECMO). This condition occurs when the heart can no longer pump enough oxygenated blood to the body. The most common cause of cardiogenic shock is damage to the heart from a severe heart attack. The standard of care for this condition for more than 20 years has a 50 percent survival rate, but improvements have recently been seen in studies using early pVAD intervention prior to percutaneous coronary intervention (PCI). For more information, visit the National Institute of Health (NIH) cardiogenic shock information page

News | Cath Lab

November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strategy ...

Home November 01, 2017
Home
News | Hemodynamic Support Devices

October 26, 2017 — Medical professionals representing hospital systems from across the United States are expected to ...

Home October 26, 2017
Home
News | Ventricular Assist Devices (VAD)

June 30, 2017 — Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic ...

Home June 30, 2017
Home
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock
Feature | Hemodynamic Support Devices | Dave Fornell

Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment ...

Home April 28, 2017
Home
Videos | Ventricular Assist Devices (VAD)

A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at Hen ...

Home April 14, 2017
Home
News | Cath Lab

April 3, 2017 — The influence of cardiac arrest and cardiogenic shock on outcomes of patients with ST-elevation ...

Home April 03, 2017
Home
News | Ventricular Assist Devices (VAD)

April 3, 2017 — Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic shock ...

Home April 03, 2017
Home
Videos | Hemodynamic Support Devices

This video, provided by Abiomed, demonstrates the Impella percutaneous ventricular assist devices (pVAD). It offers ...

Home March 21, 2017
Home
News | Ventricular Assist Devices (VAD)

March 9, 2017 — Metro Detroit cardiologists from five health systems have joined together to increase residents’ ...

Home March 09, 2017
Home
Technology | Ventricular Assist Devices (VAD)

April 11, 2016 — Abiomed Inc. announced that it has received U.S. Food and Drug Administration (FDA) pre-market approval ...

Home April 11, 2016
Home
News | ECMO Systems

September 8, 2015 — In a new study reported in The Journal of Thoracic and Cardiovascular Surgery, researchers found a ...

Home September 08, 2015
Home
The Abiomed Impella heart pump
Feature

September 11, 2012 — Primary results from an ongoing trial by Maquet Cardiovascular using intra-aortic balloon pumps ...

Home September 11, 2012
Home
News | Cardiogenic Shock

September 10, 2012 — Maquet Cardiovascular LLC announced 30-day results from the large, randomized, multicenter intra ...

Home September 10, 2012
Home
News


February 12, 2009 - Researchers in The Netherlands say the standard of care of using intra-aortic balloon pumps ...

Home February 12, 2009
Home
Subscribe Now